focus -WSS

focus

author：fashion 2025-10-01 00:45:42 - browse：43629

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： AI for drug discovery: Experts on separating hype from reality

WSS

How a small hospital in rural Puerto Rico survived Hurricane Maria

Novel spinal cord stimulator treats paralysis without surgery

Lawmakers grill UnitedHealth CEO on Change cyberattack

AstraZeneca bets AAV gene therapy will still deliver the goods

How a symptom of dementia informs our understanding of creativity

Feds fine Medicare Advantage plans for overcharging members

hotspot

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

Why more medical students aren't specializing in primary care

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Complete sequence of Y chromosome published for first time

Alkermes shareholders re

Neuroscience startup Neumora files for IPO

BioMarin wins approval for gene therapy to treat hemophilia A

How Long Island became the ‘eugenics capital of the world’

New air purifier tech could be key to improving indoor air quality

Complete sequence of Y chromosome published for first time

knowledge

Primary care doctor shortage won't be solved by free med school tuition

CDC advisory panel says seniors 'may' get RSV vaccine

AstraZeneca challenges Medicare drug negotiation program

Lawmakers grill UnitedHealth CEO on Change cyberattack

Medicare explains how it will choose drugs for negotiation

NYU Langone launches private ChatGPT for its health care data

explore

hotspot

hotspot

leisure time